Association of monetary diet cost of foods and diet quality in Spanish older adults.

Autor:	Bouzas C; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands, Palma de Mallorca, Spain.; Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain., Pastor R; Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands, Palma de Mallorca, Spain.; Faculty of Health Sciences, Catholic University of Ávila, Ávila, Spain., García S; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands, Palma de Mallorca, Spain.; Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain., Monserrat-Mesquida M; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands, Palma de Mallorca, Spain.; Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain., Martínez-González MÁ; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Preventive Medicine and Public Health, IDISNA, University of Navarra, Pamplona, Spain., Salas-Salvadó J; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Universitat Rovira i Virgili, Departament de Bioquímica i Biotecnologia, Unitat de Nutrició Humana & Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain., Corella D; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Preventive Medicine, University of Valencia, Valencia, Spain., Schröder H; Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d'Investigació Mèdica (IMIM), Barcelona, Spain.; CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain., Martínez JA; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Cardiometabolics Precision Nutrition Program, IMDEA Food, CEI UAM + CSIC, Madrid, Spain.; Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, Pamplona, Spain., Alonso-Gómez ÁM; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Bioaraba Health Research Institute, Osakidetza Basque Health Service, Araba University Hospital, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain., Wärnberg J; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Nursing, School of Health Sciences, University of Málaga-IBIMA, Málaga, Spain., Vioque J; CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Instituto de Investigación Sanitaria y Biomédica de Alicante, Universidad Miguel Hernández, ISABIAL-UMH, Alicante, Spain., Romaguera D; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain., Lopez-Miranda J; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain., Estruch R; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Internal Medicine, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain., Tinahones FJ; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Endocrinology, Virgen de la Victoria Hospital, University of Málaga, Málaga, Spain., Lapetra J; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Family Medicine, Research Unit, Distrito Sanitario Atención Primaria Sevilla, Sevilla, Spain., Serra-Majem L; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Institute for Biomedical Research, University of Las Palmas de Gran Canaria, Las Palmas, Spain., Riquelme-Gallego B; CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Preventive Medicine, University of Granada, Granada, Spain., Romero-Secin A; CIBER Diabetes y Enfermedades Metabólicas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Consultorio de Colloto, Centro de Salud Ventanielles, Oviedo, Spain., Pintó X; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Lipids and Vascular Risk Unit, Internal Medicine, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain., Gaforio JJ; CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Health Sciences, Center for Advanced Studies in Olive Grove and Olive Oils, University of Jaén, Jaén, Spain., Matía P; Department of Endocrinology and Nutrition, Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clínico San Carlos, Universidad Complutense, Madrid, Spain., Vidal J; Department of Endocrinology, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain., Zapatero M; Department of Endocrinology, Hospital La Paz, Madrid, Spain., Daimiel L; Nutritional Control of the Epigenome Group, Precision Nutrition and Obesity Program, IMDEA Food, CEI UAM + CSIC, Madrid, Spain., Ros E; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Lipid Clinic, Department of Endocrinology and Nutrition, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain., García-Arellano A; Department of Preventive Medicine and Public Health, IDISNA, University of Navarra, Pamplona, Spain.; Osasunbidea, Servicio Navarro de Salud, Atención Primaria, Pamplona, Spain., Babio N; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Universitat Rovira i Virgili, Departament de Bioquímica i Biotecnologia, Unitat de Nutrició Humana & Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain., Gonzalez-Monje I; Department of Preventive Medicine, University of Valencia, Valencia, Spain., Castañer O; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d'Investigació Mèdica (IMIM), Barcelona, Spain., Abete I; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, Pamplona, Spain., Tojal-Sierra L; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Bioaraba Health Research Institute, Osakidetza Basque Health Service, Araba University Hospital, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain., Benavente-Marín JC; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Nursing, School of Health Sciences, University of Málaga-IBIMA, Málaga, Spain., Signes-Pastor A; CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Instituto de Investigación Sanitaria y Biomédica de Alicante, Universidad Miguel Hernández, ISABIAL-UMH, Alicante, Spain., Konieczna J; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain., García-Ríos A; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain., Castro-Barquero S; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Internal Medicine, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain., Fernández-García JC; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Endocrinology, Virgen de la Victoria Hospital, University of Málaga, Málaga, Spain., Santos-Lozano JM; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Family Medicine, Research Unit, Distrito Sanitario Atención Primaria Sevilla, Sevilla, Spain., Bes-Rastrollo M; Department of Preventive Medicine and Public Health, IDISNA, University of Navarra, Pamplona, Spain., Mestres C; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Universitat Rovira i Virgili, Departament de Bioquímica i Biotecnologia, Unitat de Nutrició Humana & Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain., Guillem-Saiz P; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Preventive Medicine, University of Valencia, Valencia, Spain., Goday A; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d'Investigació Mèdica (IMIM), Barcelona, Spain., Goicolea-Güemez L; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Bioaraba Health Research Institute, Osakidetza Basque Health Service, Araba University Hospital, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain., Puig-Aguiló E; Centro Salud de San Juan, San Juan de Alicante, Spain., Ruiz-Canela M; Department of Preventive Medicine and Public Health, IDISNA, University of Navarra, Pamplona, Spain., Palau-Galindo A; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Universitat Rovira i Virgili, Departament de Bioquímica i Biotecnologia, Unitat de Nutrició Humana & Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.; ABS Reus V. Centre d'Assistència Primària Marià Fortuny, Salut Sant Joan de Reus-Baix Camp, Reus, Spain., Fitó M; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d'Investigació Mèdica (IMIM), Barcelona, Spain., Tur JA; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands, Palma de Mallorca, Spain.; Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain.
Jazyk:	angličtina
Zdroj:	Frontiers in public health [Front Public Health] 2023 Jul 25; Vol. 11, pp. 1166787. Date of Electronic Publication: 2023 Jul 25 (Print Publication: 2023).
DOI:	10.3389/fpubh.2023.1166787
Abstrakt:	Background: A major barrier to a healthy diet may be the higher price of healthy foods compared to low-quality foods. Objectives: This study aimed to assess the association between the monetary cost of food and diet quality in Spanish older adults at high risk of cardiovascular disease. Methods: Cross-sectional analysis was carried out in Spanish older adults ( n = 6,838; 48.6% female). A validated food frequency questionnaire was used to assess dietary intake. Metabolic syndrome severity, adherence to the Mediterranean diet (MedDiet), adherence to a provegetarian dietary pattern, and dietary inflammatory index were assessed. The economic cost of the foods was obtained from the Spanish Ministry of Agriculture Fisheries and Food database (2015-2017, the period of time when the participants were recruited). The total cost of diet adjusted per 1,000 kcal was computed. Results: The healthier dietary pattern was associated with a higher cost of the diet. Higher adherence to the MedDiet, anti-inflammatory diet, and the healthy version of the provegetarian dietary pattern were related to higher costs of the diet. Conclusion: Higher diet quality was associated with a higher dietary cost of the diet per 1,000 kcal/day. Food prices can be an important component of interventions and policies aimed at improving people's diets and preventing diet-related chronic diseases. Clinical Trial Registry Number: The trial was registered in 2014 at the International Standard Randomized Controlled Trial (ISRCT; http://www.isrctn.com/ISRCTN89898870) with the number 89898870. Competing Interests: JS-S reports serving on the board of and receiving grant support through his institution from the International Nut and Dried Fruit Council, and Eroski Foundation. Reports serving in the Executive Committee of the Instituto Danone Spain and on the Scientific Committee of the Danone International Institute. He has received research support from Patrimonio Comunal Olivarero, Spain and Borges SA, Spain. Reports receiving consulting fees or travel expenses from Danone; Eroski Foundation, Instituto Danone, Spain, and Abbot Laboratories. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer MM-A declared a shared affiliation with the author BR-G to the handling editor at the time of review. (Copyright © 2023 Bouzas, Pastor, García, Monserrat-Mesquida, Martínez-González, Salas-Salvadó, Corella, Schröder, Martínez, Alonso-Gómez, Wärnberg, Vioque, Romaguera, Lopez-Miranda, Estruch, Tinahones, Lapetra, Serra-Majem, Riquelme-Gallego, Romero-Secin, Pintó, Gaforio, Matía, Vidal, Zapatero, Daimiel, Ros, García-Arellano, Babio, Gonzalez-Monje, Castañer, Abete, Tojal-Sierra, Benavente-Marín, Signes-Pastor, Konieczna, García-Ríos, Castro-Barquero, Fernández-García, Santos-Lozano, Bes-Rastrollo, Mestres, Guillem-Saiz, Goday, Goicolea-Güemez, Puig-Aguiló, Ruiz-Canela, Palau-Galindo, Fitó and Tur.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu